Keyphrases
Research Partnerships
100%
Systemic Juvenile Idiopathic Arthritis (sJIA)
100%
Childhood Arthritis
100%
Rheumatology Research
100%
Disease Activity
60%
Medication Use
40%
Disease Duration
40%
Systemic Symptoms
40%
Persistent Arthritis
40%
Joint Counts
40%
Disease-modifying Antirheumatic Drugs (DMARDs)
20%
Multivariate Analysis
20%
Clinical Characteristics
20%
Improved Outcomes
20%
Poor Prognosis
20%
Disease Activity Score
20%
Patient Characteristics
20%
African American
20%
Functional Status
20%
Fever
20%
Rash
20%
Practice Patterns
20%
Descriptive Statistics
20%
African American Patients
20%
Biological Agents
20%
Rheumatology
20%
Frequency of Use
20%
Tumour Necrosis Factor Inhibitor (TNFi)
20%
Chronic Arthritis
20%
Physician Global Assessment
20%
Low Disease Activity
20%
Characteristic 2
20%
IL-6 Inhibitor
20%
Usage Trends
20%
Interleukin-1 Inhibitors
20%
Arthritis Symptoms
20%
Medicine and Dentistry
Arthritis
100%
Rheumatology
100%
Systemic Juvenile Idiopathic Arthritis
100%
Disease Activity
83%
Disease Duration
33%
Interleukin 1
16%
Biological Product
16%
Interleukin 6
16%
Multivariate Analysis
16%
Glucocorticoid
16%
Exanthem
16%
Functional Status
16%
TNF Inhibitor
16%
Disease Modifying Antirheumatic Drug
16%
Chronic Arthritis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Arthritis
100%
Systemic Juvenile Idiopathic Arthritis
100%
Disease Activity
83%
Disease Duration
33%
Disease Modifying Antirheumatic Drug
16%
Glucocorticoid
16%
Interleukin 1
16%
Biological Product
16%
Functional Status
16%
Interleukin 6
16%
Rash
16%
Tumor Necrosis Factor Inhibitor
16%
Chronic Arthritis
16%
Immunology and Microbiology
Juvenile Idiopathic Arthritis
100%
Childhood Arthritis
100%
Arthritis
80%
Interleukin 1
20%
Interleukin 6
20%
Biological Product
20%
Functional Status
20%
TNF Inhibitor
20%
Disease-Modifying Antirheumatic Drug
20%
Glucocorticoid
20%